Showing results (141-150 of 330) with videos related to
Sort By:
Pageof 33
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standardJennifer R Won, Dongxia Gao, Christine Chow, et al.Annals of Surgical Oncology|January 18, 2023
Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast CancerKelly K Hunt, Vera J Suman, Hannah F Wingate, et al.Cold Spring Harbor Perspectives in Medicine|May 3, 2023
The Breast Cancer Proteome and Precision OncologyJonathan T Lei, Eric J Jaehnig, Hannah Smith, et al.Plos One|July 8, 2016
Human Blood Autoantibodies in the Detection of Colorectal CancerOla H Negm, Mohamed R Hamed, Robert E Schoen, et al.Nature Communications|May 20, 2021
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancerNindo B Punturi, Sinem Seker, Vaishnavi Devarakonda, et al.Clinical Proteomics|January 15, 2024
Kinase inhibitor pulldown assay (KiP) for clinical proteomicsAlexander B Saltzman, Doug W Chan, Matthew V Holt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast CancerIman Doostan, Cansu Karakas, Mehrnoosh Kohansal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECTStephen Chia, William Gradishar, Louis Mauriac, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast CancersMilana A Bergamino, Gabriele Morani, Joel Parker, et al.Case Reports in Urology|January 11, 2021
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint InhibitorRyan S Chiang, Ashton A Connor, Brant A Inman, et al.Pageof 33